You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
北大醫藥(000788.SZ):取得鹽酸莫西沙星注射液的藥品註冊批件 可用於治療成人敏感細菌所引起的感染
格隆匯 02-03 20:22

格隆匯2月3日丨北大醫藥(000788.SZ)公佈,公司股票價格於2020年1月23日、2月3日連續二個交易日收盤價格漲幅偏離值累積超過20%,根據《深圳證券交易所交易規則》的有關規定,屬於股票交易異常波動的情況。

經核查,公司未發現近期公共媒體報道了可能或已經對公司股票交易價格產生較大影響的未公開重大信息。針對“新型冠狀病毒感染的肺炎疫情”,公司已緊急成立疫情防控工作領導小組,要求公司及子公司上下聯動,全力保障藥品、器械、醫用耗材等防控物資的供應,盡一切可能優先保障醫院需求,為奮戰在疫情最前線的醫務工作者們提供強有力的後盾。公司於近期取得鹽酸莫西沙星注射液的藥品註冊批件,該藥品可用於治療成人(≥18歲)敏感細菌所引起的感染,包括社區獲得性肺炎、急性細菌性鼻竇炎、慢性支氣管炎急性發作、複雜性腹腔內感染、皮膚和皮膚組織感染等,公司將盡快啟動生產及銷售工作。

另外,2019123日,公司接到北大方正集團有限公司(“方正集團”)《通知函》,通知函涉及引入大型央企作為戰略投資人,方正集團實際控制人可能發生變更的內容,該事項存在重大不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account